Clinical trial
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in…
NCT00426478 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00426478 |
|---|---|
| Title | Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients |
| Official title | The Comparison of the Antihypertensive Efficacy and Tolerability Between Valsartan Plus Hydrochlorothiazide 80mg/12.5mg and Amlodipine 5mg in the Essential Hypertensive Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan plus Hydrochlorothiazide (80mg/12.5mg), Amlodipine (5mg) |
| Enrollment | 80 |
| Start date | Nov 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Jan 24, 2007 |
| Last update posted | Aug 22, 2008 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: